|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Loss for the year | |||||
| Add items not affecting cash / adjustments: | |||||
| Depreciation | |||||
| Interest expense | |||||
| Unrealized foreign exchange gain | |||||
| Gain on fair value of derivatives and other instruments | |||||
| Loss on repayment of debt and convertible notes | |||||
| Gain on extension of Sprott Facility | |||||
| Deferred income tax expense | |||||
| Stock based compensation expense | |||||
| Interest from short-term investments | |||||
| Share unit settlement | |||||
| Share of joint venture expenditures | |||||
| Directors' fees paid in deferred share units | |||||
| Write-off costs associated with prospecting right closure | |||||
| Net change in non-cash working capital | |||||
| Net cash flows from (used in) operating activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from issuance of equity | |||||
| Equity issuance costs | |||||
| Share unit cash settlement | |||||
| Sprott Facility principal repayments | |||||
| Sprott Facility interest paid | |||||
| Convertible note interest paid | |||||
| Costs associated with repayment of debt and convertible debt | |||||
| Cash received from option exercises | |||||
| Lease payments made | |||||
| Cash received from Waterberg partners | |||||
| Net cash flows from (used in) financing activities | |||||
| INVESTING ACTIVITIES | |||||
| Performance bonds | |||||
| Acquisition of short-term investments | |||||
| Disposal of short-term investments | |||||
| Interest received from short-term investments | |||||
| Investment in Lion | |||||
| Expenditures incurred on Waterberg Project | |||||
| Net cash flows from (used in) investing activities | |||||
| Net decrease in cash | |||||
| Effect of foreign exchange on cash | |||||
| Cash, beginning of year | |||||
| Cash, end of year | |||||
Loading...